BioCentury
ARTICLE | Clinical News

Arilvax live attenuated yellow fever vaccine regulatory update

February 23, 2004 8:00 AM UTC

ACM temporarily withdrew a BLA for Arilvax vaccine to prevent yellow fever, and expects to resubmit the BLA in the first half of 2005. ACM said that CHIR subsidiary Chiron Vaccines is planning to upgr...